Molecular Diagnostics Market to reach USD 32.37 Billion by 2032, and grow at a CAGR of 9.07%
The molecular diagnostics market is surging due to several key advancements and growing applications. Recent years have seen the introduction of powerful tools like shotgun metagenomic next-generation sequencing (NGS). This technology provides a comprehensive analysis, identifying a vast range of microorganisms in a single test. Additionally, the MSI Analysis System aids in detecting microsatellite instability, a crucial marker for certain cancers. Advancements in sample preparation methods, like NANOPEC, further enhance accuracy by reducing the risk of false negatives. These innovations are making molecular diagnostics more reliable and versatile, driving market adoption.